Seqstant Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.94M

  • Investors
  • 5

Seqstant General Information

Description

Developer of a live-gene analysis platform designed to offer sensitive, specific, and user-friendly real-time genetic diagnostics. The company offers a metagenomic diagnostics platform that automates the analysis process for pathogens, resistance genes, and quality control and ensures interoperability for analytics from a single source, enabling clients to have an in-house system for better treatment, reduced analysis effort, and end-to-end services in bioinformatics.

Contact Information

Website
www.seqstant.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rheinstrasse 11
  • 14513 Teltow
  • Germany
Primary Industry
Business/Productivity Software
Other Industries
Other Healthcare Technology Systems
Vertical(s)
SaaS, Life Sciences
Corporate Office
  • Rheinstrasse 11
  • 14513 Teltow
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seqstant Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 28-Nov-2023 $1.94M Completed Generating Revenue
To view Seqstant’s complete valuation and funding history, request access »

Seqstant Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 4

    Pending

  • Expiring in next 12 mo

Seqstant Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022278434-A1 Method for parallel real-time sequence analysis Pending 19-May-2021
CA-3218561-A1 Method for parallel real-time sequence analysis Pending 19-May-2021
EP-4341436-A1 Method for parallel real-time sequence analysis Pending 19-May-2021
US-20260055453-A1 Method for parallel real-time sequence analysis Pending 19-May-2021
WO-2022243192-A1 Method for parallel real-time sequence analysis Inactive 19-May-2021 C12Q1/6874
To view Seqstant’s complete patent history, request access »

Seqstant Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seqstant Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Brandenburg Kapital Venture Capital Minority
Hasso Plattner Venture Capital Venture Capital Minority
JCMB Beteiligungs Other Minority
SVEDA Vermögens Family Office Minority
Venture League Angel Group Minority
To view Seqstant’s complete investors history, request access »

Ready to get started?

Request a free trial

Seqstant FAQs

  • When was Seqstant founded?

    Seqstant was founded in 2021.

  • Where is Seqstant headquartered?

    Seqstant is headquartered in Teltow, Germany.

  • What is the size of Seqstant?

    Seqstant has 10 total employees.

  • What industry is Seqstant in?

    Seqstant’s primary industry is Business/Productivity Software.

  • Is Seqstant a private or public company?

    Seqstant is a Private company.

  • What is Seqstant’s current revenue?

    The current revenue for Seqstant is .

  • How much funding has Seqstant raised over time?

    Seqstant has raised $1.94M.

  • Who are Seqstant’s investors?

    Brandenburg Kapital, Hasso Plattner Venture Capital, JCMB Beteiligungs, SVEDA Vermögens, and Venture League have invested in Seqstant.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process